High volatility in Arbutus Biopharma Corporation stock price on Wednesday which ended trading at $4.14
(Updated on Dec 08, 2021)
Buy or Hold candidate since 2021-12-01 Loss -10.20% PDF
The Arbutus Biopharma Corporation stock price gained 4.55% on the last trading day (Wednesday, 8th Dec 2021), rising from $3.96 to $4.14. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 11.23% from a day low at $3.83 to a day high of $4.26. The price has risen in 6 of the last 10 days and is up by 32.69% over the past 2 weeks. Volume fell on the last day by -12 million shares and in total, 8 million shares were bought and sold for approximately $32.48 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.44% during the next 3 months and, with a 90% probability hold a price between $2.43 and $3.74 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast
The Arbutus Biopharma Corporation stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.01 and $3.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, December 06, 2021, and so far it has risen 11.59%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss
Arbutus Biopharma Corporation finds support from accumulated volume at $4.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.43 between high and low, or 11.23%. For the last week, the stock has had a daily average volatility of 14.69%.
Our recommended stop-loss: $4.01 (-3.24%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 2 days ago.)
Is Arbutus Biopharma Corporation stock A Buy?
Arbutus Biopharma Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.704
Predicted Opening Price for Arbutus Biopharma Corporation of Thursday, December 9, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 9, 2021||Current price|
Remember To Visit Our YouTube Channel
On Dec 02, 2021 "Chardan Capital" gave "$5.00 - $5.50" rating for ABUS. The price target was set to $4.61.
ABUS Insider Trading
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.